In the #0excludeGlossary world of cannabis, Tilray stands out as a pioneering force. Established in 2013, Tilray is a Canadian company that has made significant strides in the cultivation, research, and distribution of cannabis products. The name “Tilray” was chosen to reflect a forward-thinking approach, combining elements of trust and innovation. While it doesn’t have deep historical roots, Tilray has quickly become a household name in the cannabis sector. Over the years, the meaning of Tilray has expanded beyond just a brand; it now signifies a commitment to advancing cannabis science and providing high-quality products to consumers worldwide. As the industry continues to grow, Tilray’s influence and reputation remain strong, making it a key player in shaping the future of cannabis. [Source: Tilray.com, Business Insider]
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand,Latin America, with growing facilities in Germany, Portugal and the United Kingdom.
 | |
| Company type | Public |
|---|---|
| Nasdaq: TLRY TSX: TLRY | |
| Industry | Cannabis, Pharmaceuticals, Brewing |
| Founded | 2013 |
| Founder | Brendan Kennedy |
| Headquarters | New York City , United States |
Key people | Irwin D. Simon (CEO) |
| Revenue |  US$789 million (2024) |
| US$-222 million (2024) | |
Number of employees | 1,600 (2023) |
| Website | tilray |
In December 2020, the company announced a merger with Aphria, and now operates under the Tilray name and its ticker symbol on NASDAQ and the Toronto Stock Exchange.
Tilray also owns several breweries and was ranked by the Brewers Association as the 4th largest craft beer company in the US in 2025.